Andrew Murphy
- Immunology top 0.5%
- Immune cells in cancer 30
- Atherosclerosis and Cardiovascular Diseases 27
- Immune Cell Function and Interaction 14
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
- Cancer Research top 2%
- Surgery top 1%
- Cholesterol and Lipid Metabolism 20
- Lipoproteins and Cardiovascular Health 14
-
- Adipokines, Inflammation, and Metabolic Diseases 31
-
- Peroxisome Proliferator-Activated Receptors 14
- Co-authors
- Alan R. TallKevin WoollardPrabhakara R. NagareddyMarit WesterterpJaye Chin‐DustingLaurent Yvan‐CharvetDmitri SviridovRoslynn A. Stirzaker
- Journals
- Circulation Research (12 papers)Arteriosclerosis Thrombosis and Vascular Biology (11 papers)Atherosclerosis (9 papers)
- Partner nations
- AustraliaUnited StatesNetherlands
In The Last Decade
Andrew Murphy
195 papers receiving 9.4k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Immunology 3.1k
- Endocrinology, Diabetes and Metabolism 1.4k
- Cancer Research 1.0k
- Cardiology and Cardiovascular Medicine 1.4k
- Surgery 2.5k
Countries citing papers authored by Andrew Murphy
This map shows the geographic impact of Andrew Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Murphy more than expected).
Fields of papers citing papers by Andrew Murphy
This network shows the impact of papers produced by Andrew Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Murphy. The network helps show where Andrew Murphy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 24 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 17 | |
| 9 | 2023 | 4 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 72 | |
| 12 | 2021 | 11 | |
| 13 | 2021 | 6 | |
| 14 | 2021 | 51 | |
| 15 | 2021 | 36 | |
| 16 | 2020 | 33 | |
| 17 | 2020 | 47 | |
| 18 | 2020 | 68 | |
| 19 | 2018 | 40 | |
| 20 | Preliminary results from a new seismic network in the northeastern Caribbean | 1979 | 26 |
About Andrew Murphy
Andrew Murphy is a scholar working on Immunology, Hematology and Endocrinology, Diabetes and Metabolism, having authored 203 papers that have together received 9.5k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (31 papers), Immune cells in cancer (30 papers), Atherosclerosis and Cardiovascular Diseases (27 papers), Cholesterol and Lipid Metabolism (20 papers), Lipoproteins and Cardiovascular Health (14 papers), Immune Cell Function and Interaction (14 papers), Peroxisome Proliferator-Activated Receptors (14 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers). The work is most often cited by research in Immunology (3.1k citations), Endocrinology, Diabetes and Metabolism (1.4k citations) and Cancer Research (1.0k citations). Andrew Murphy has collaborated with scholars based in Australia, United States and Netherlands. Frequent co-authors include Alan R. Tall, Kevin Woollard, Prabhakara R. Nagareddy, Marit Westerterp, Jaye Chin‐Dusting, Laurent Yvan‐Charvet, Dmitri Sviridov, Roslynn A. Stirzaker, Michael J. Kraakman and Dragana Dragoljevic. Their work appears in journals such as Circulation Research, Arteriosclerosis Thrombosis and Vascular Biology, Atherosclerosis, Clinical & Translational Immunology and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.